SPK-RPE65

Shares of Spark Therapeutics Inc (NASDAQ: ONCE) opened higher by more than 40 percent on Monday. Spark's product candidate, SPK-RPE65, targets a group of rare blinding conditions known as inherited retinal dystrophies. Spark announced on Monday its SPK-RPE65 met the goals of a late-stage study....

Six companies are set to go public on Friday. Below are details on the most anticipated biotech deal of the week. The two best deals of the week are thought to be Spark Therapeutics Inc (NASDAQ: ONCE) and Shake Shack (NYSE: SHAK). Spark Therapeutics is a gene therapy company focused on...